Attention-deficit hyperactivity disorders. Attention-deficit hyperactivity disorders
Conditions
Interventions
Intervention 1: Intervention group: tizanidine tablet (Tizanidine 4MG TAB, Hakim Pharmacy) with dose 1-4mg daily, divided doses orally for 2 month. Intervention 2: Control group: placebo tablet(School
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
9 Years to 18 Years
Inclusion criteria
Inclusion criteria: Clinical diagnosis of Attention Deficit Hyperactivity Disorder according to DSM-5 criteria completing the informed consent form by parent and patient negative history for any chronic medical diseases negative history for drug induced allergy negative history of receiving any Anti hypertensive, Alpha blockers or Beta blockers during recent three months before study Lack of history of any comorbid psychiatric disorder
Exclusion criteria
Exclusion criteria: Any unexpected physical or mental condition that effects on treatment regimen unwillingness of patients or parents to continue study procedure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ADHD severity. Timepoint: Before intervention and 1,2 months after intervention. Method of measurement: conners questioner. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Before intervention and 1,2 months after intervention. Method of measurement: Standard mercury sphygmomanometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMostafa Haghshenas
Esfahan University of Medical Sciences
Outcome results
None listed